VS
Vicki L Sato
Director

Vicki L Sato insider trades: Vir Biotechnology (VIR) stock sales

Director, Vir Biotechnology Last trade May 1, 2026 148 Form 4 filings
$1.1M
Sold, last 12 months
6 sales
$0
Bought, last 12 months
0 buys
72
Open-market trades
since 2005
12
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Vicki reports to the SEC

and 6 more companies

Open-market buys and sales

72 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 1, 2026VIR↓ Sell$221K
Apr 1, 2026VIR↓ Sell$200K
Mar 2, 2026VIR↓ Sell$209K
Feb 2, 2026VIR↓ Sell$170K
Jan 2, 2026VIR↓ Sell$130K
Dec 1, 2025VIR↓ Sell$132K
Nov 3, 2025VIR↓ Sell$124K
Oct 1, 2025VIR↓ Sell$128K
Sep 2, 2025VIR↓ Sell$110K
Aug 1, 2025VIR↓ Sell$110K
Jul 1, 2025VIR↓ Sell$112K
Jan 8, 2025VIR↓ Sell$137K
Jan 2, 2025DNLI↓ Sell$64K
Nov 7, 2024DNLI↓ Sell$31K
Nov 1, 2024DNLI↓ Sell$83K
Sep 13, 2024DNLI↓ Sell$31K
Sep 3, 2024DNLI↓ Sell$77K
Jul 1, 2024DNLI↓ Sell$68K
May 15, 2024DNLI↓ Sell$34K
Apr 15, 2024DNLI↓ Sell$30K
Mar 15, 2024DNLI↓ Sell$33K
Feb 15, 2024DNLI↓ Sell$31K
Jan 16, 2024DNLI↓ Sell$31K
Dec 15, 2023DNLI↓ Sell$39K
Nov 15, 2023DNLI↓ Sell$32K
Oct 16, 2023DNLI↓ Sell$34K
Sep 15, 2023DNLI↓ Sell$39K
Aug 15, 2023DNLI↓ Sell$40K
Jul 17, 2023DNLI↓ Sell$49K
Jun 30, 2023VIR↓ Sell$444K
Jun 28, 2023DNLI↓ Sell$50K
Mar 8, 2023VIR↓ Sell$405K
Feb 8, 2023VIR↓ Sell$508K
Jan 9, 2023VIR↓ Sell$463K
Dec 8, 2022VIR↓ Sell$462K
Nov 8, 2022VIR↓ Sell$491K
Oct 10, 2022VIR↓ Sell$370K
Sep 8, 2022VIR↓ Sell$392K
Aug 8, 2022VIR↓ Sell$543K
Jul 8, 2022VIR↓ Sell$521K
Jun 8, 2022VIR↓ Sell$463K
May 24, 2022VIR↓ Sell$80K
May 9, 2022VIR↓ Sell$300K
Apr 28, 2022VIR↓ Sell$374K
Jan 18, 2022VIR↓ Sell$567K
Dec 20, 2021VIR↓ Sell$827K
Nov 26, 2021VIR↓ Sell$558K
Nov 10, 2021DNLI↓ Sell$88K
Nov 1, 2021DNLI↓ Sell$83K
Oct 19, 2021VIR↓ Sell$600K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other VIR insiders

Open-market trades in the last 12 months

About Vicki L Sato's insider trades

Vicki L Sato is a director at Vir Biotechnology (VIR). Since May 11, 2005, Vicki has reported no open-market purchases and 72 sales worth $19.2M on SEC Form 4. In the last 12 months: 6 sales ($1.1M).

Their filings also include grants and awards (76 filings), option exercises (8 filings), shares returned to the company (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VIR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.